Ram I Mahato (Ram Mahato)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Cell death discovery

Biomolecules

ACS applied materials & interfaces

Medicinal research reviews

Buffet Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska

University of Strathclyde (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Buffet Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska

United States

Professor :: Buffett Cancer Center

University of Nebraska Medical Center College of Pharmacy

United States

Professor and Chair :: Pharmaceutical Sciences

University of Tennessee Health Science Center

United States

Adjunct Professor :: Department of Biomedical Engineering

University of Tennessee Health Science Center

United States

Professor :: Pharmaceutical Sciences

University of Tennessee Health Science Center

United States

Associate Professor :: Pharmaceutical Sciences

University of Tennessee Health Science Center

United States

Assistant Professor :: Pharmaceutical Sciences

University of Utah

United States

Research Assistant Professor :: Pharmaceutics and Pharmaceutical Chemistry

Copernicus Therapeutics, Inc.

United States

Manager :: Pharmaceutical Development

GeneMedicine, Inc.

United States

Senior Scientist :: Gene Delivery Sciences

Education History

University of Strathclyde

United Kingdom

PHD :: Pharmaceutics and Drug Delivery

China Pharmaceutical University School of Pharmacy

China

BSC :: Pharmaceutics

Publications

Natalia A Osna, Irina Tikhanovich, Marti Ortega-Ribera, Sebastian Mueller, Chaowen Zheng, Johannes Mueller, Siyuan Li, Sadatsugu Sakane, Raquel Carvalho Gontijo Weber, Hyun Young Kim, Wonseok Lee, Souradipta Ganguly, Yusuke Kimura, Xiao Liu, Debanjan Dhar, Karin Diggle, David A Brenner, Tatiana Kisseleva, Neha Attal, Iain H McKillop, Shilpa Chokshi, Ram I Mahato, Karuna Rasineni, Gyongyi Szabo, Kharbanda K Kusum
Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression. Biomolecules 14 (4) (2024)
Virender Kumar, Bharti Sethi, Dalton W Staller, Prakash Shrestha, Ram I Mahato
Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model. Cell death discovery 10 (1) (2024)
Natalia A Osna, Irina Tikhanovich, Marti Ortega-Ribera, Sebastian Mueller, Chaowen Zheng, Johannes Mueller, Siyuan Li, Sadatsugu Sakane, Raquel Carvalho Gontijo Weber, Hyun Young Kim, Wonseok Lee, Souradipta Ganguly, Yusuke Kimura, Xiao Liu, Debanjan Dhar, Karin Diggle, David A Brenner, Tatiana Kisseleva, Neha Attal, Iain H McKillop, Shilpa Chokshi, Ram I Mahato, Karuna Rasineni, Gyongyi Szabo, Kharbanda K Kusum
Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression. Biomolecules 14 (4) (2024)
Virender Kumar, Bharti Sethi, Dalton W Staller, Prakash Shrestha, Ram I Mahato
Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model. Cell death discovery 10 (1) (2024)
Natalia A Osna, Irina Tikhanovich, Marti Ortega-Ribera, Sebastian Mueller, Chaowen Zheng, Johannes Mueller, Siyuan Li, Sadatsugu Sakane, Raquel Carvalho Gontijo Weber, Hyun Young Kim, Wonseok Lee, Souradipta Ganguly, Yusuke Kimura, Xiao Liu, Debanjan Dhar, Karin Diggle, David A Brenner, Tatiana Kisseleva, Neha Attal, Iain H McKillop, Shilpa Chokshi, Ram I Mahato, Karuna Rasineni, Gyongyi Szabo, Kharbanda K Kusum
Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression. Biomolecules 14 (4) (2024)
Prakash Shrestha, Yashwardhan Ghanwatkar, Sohan Mahto, Nilkamal Pramanik, Ram I Mahato
Gemcitabine-Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice. ACS applied materials & interfaces 16 (23) (2024)
Prakash Shrestha, Yashwardhan Ghanwatkar, Sohan Mahto, Nilkamal Pramanik, Ram I Mahato
Gemcitabine-Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice. ACS applied materials & interfaces (2024)
Virender Kumar, Bharti Sethi, Dalton W Staller, Prakash Shrestha, Ram I Mahato
Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model. Cell death discovery 10 (1) (2024)
Natalia A Osna, Irina Tikhanovich, Marti Ortega-Ribera, Sebastian Mueller, Chaowen Zheng, Johannes Mueller, Siyuan Li, Sadatsugu Sakane, Raquel Carvalho Gontijo Weber, Hyun Young Kim, Wonseok Lee, Souradipta Ganguly, Yusuke Kimura, Xiao Liu, Debanjan Dhar, Karin Diggle, David A Brenner, Tatiana Kisseleva, Neha Attal, Iain H McKillop, Shilpa Chokshi, Ram I Mahato, Karuna Rasineni, Gyongyi Szabo, Kharbanda K Kusum
Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression. Biomolecules 14 (4) (2024)
Virender Kumar, Bharti Sethi, Dalton W Staller, Prakash Shrestha, Ram I Mahato
Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model. Cell death discovery 10 (1) (2024)
Dalton W Staller, Sanjali S Panigrahi, Yahani P Jayasinghe, Yuxiang Dong, Sohan Mahto, Virender Kumar, Donald R Ronning, Ram I Mahato
A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases. Hepatology (Baltimore, Md.) (2024)
Virender Kumar, Bharti Sethi, Dalton W Staller, Prakash Shrestha, Ram I Mahato
Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model. Cell death discovery 10 (1) (2024)
Ram I Mahato, Virender Kumar, Bhartu Sethi, Dalton Staller
Gemcitabine elaidate and ONC201 combination therapy inhibits pancreatic cancer in a KRAS mutated syngeneic mouse model. Research square (2023)
Jingyi Ma, Virender Kumar, Ram I Mahato
Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease. Pharmaceutics 14 (9) (2022)
Xiaofei Xin, Virender Kumar, Feng Lin, Vinod Kumar, Rajan Sharma Bhattarai, Vijaya Raj Bhatt, Chalet Tan, Ram I Mahato
Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy. Science advances 6 (46) (2020)
Xiaofei Xin, Feng Lin, Qiyue Wang, Lifang Yin, Ram I Mahato
ROS-Responsive Polymeric Micelles for Triggered Simultaneous Delivery of PLK1 Inhibitor/miR-34a and Effective Synergistic Therapy in Pancreatic Cancer. ACS applied materials & interfaces 11 (16) (2019)
Bikash R Giri, Ram I Mahato, Guofeng Cheng
Roles of microRNAs in T cell immunity: Implications for strategy development against infectious diseases. Medicinal research reviews 39 (2) (2018)
Jitender Bariwal, Virender Kumar, Yuxiang Dong, Ram I Mahato
Design of Hedgehog pathway inhibitors for cancer treatment. Medicinal research reviews 39 (3) (2018)
Saurabh Sharma, Samrat Mazumdar, Kishan S Italiya, Tushar Date, Ram I Mahato, Anupama Mittal, Deepak Chitkara
Cholesterol and Morpholine Grafted Cationic Amphiphilic Copolymers for miRNA-34a Delivery. Molecular pharmaceutics 15 (6) (2018)
Goutam Mondal, Saud Almawash, Amit Kumar Chaudhary, Ram I Mahato
EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer. Molecular pharmaceutics 14 (9) (2017)

Ram I Mahato.css-eqlu8i{font-size:small;padding-left:4px;} (Ram Mahato)

Publication Activity (10 Years)

Top Topics

Top Venues

Ram I Mahato (Ram Mahato)